Cargando…
ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury
Angiotensin-converting enzyme 2 (ACE2) is the carboxypeptidase to degrade angiotensin II (Ang II) to angiotensin 1–7 (Ang 1–7) and improves the pathologies of cardiovascular disease and acute respiratory distress syndrome (ARDS)/acute lung injury. B38-CAP is a bacteria-derived ACE2-like carboxypepti...
Autores principales: | Minato, Takafumi, Yamaguchi, Tomokazu, Hoshizaki, Midori, Nirasawa, Satoru, An, Jianbo, Takahashi, Saori, Penninger, Josef M., Imai, Yumiko, Kuba, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307200/ https://www.ncbi.nlm.nih.gov/pubmed/35867642 http://dx.doi.org/10.1371/journal.pone.0270920 |
Ejemplares similares
-
B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction
por: Minato, Takafumi, et al.
Publicado: (2020) -
ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury
por: Yamaguchi, Tomokazu, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021) -
Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
por: Kuba, Keiji, et al.
Publicado: (2006) -
Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters
por: Kuba, Keiji, et al.
Publicado: (2010)